Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1975 1
1979 1
1981 2
1982 1
1986 3
1987 3
1988 4
1989 4
1990 4
1991 4
1992 5
1993 5
1994 2
1995 8
1996 13
1997 6
1998 9
1999 12
2000 13
2001 22
2002 11
2003 26
2004 25
2005 30
2006 32
2007 40
2008 52
2009 42
2010 42
2011 53
2012 55
2013 90
2014 106
2015 119
2016 119
2017 126
2018 154
2019 178
2020 227
2021 258
2022 273
2023 263
2024 325
2025 384
2026 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,814 results

Results by year

Filters applied: . Clear all
Page 1
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China.
Xiong A, Wang L, Chen J, Wu L, Liu B, Yao J, Zhong H, Li J, Cheng Y, Sun Y, Ge H, Yao J, Shi Q, Zhou M, Chen B, Han Z, Wang J, Bu Q, Zhao Y, Chen J, Nie L, Li G, Li X, Yu X, Ji Y, Sun D, Ai X, Chu Q, Lin Y, Hao J, Huang D, Zhou C, Shan J, Yang H, Liu X, Wang J, Shang Y, Mei X, Yang J, Lu D, Hu M, Wang ZM, Li B, Xia M, Zhou C. Xiong A, et al. Among authors: nie l. Lancet. 2025 Mar 8;405(10481):839-849. doi: 10.1016/S0140-6736(24)02722-3. Lancet. 2025. PMID: 40057343 Clinical Trial.
In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer.
Feng X, Yang C, Huang Y, Su D, Wang C, Wilson LL, Yin L, Tang M, Li S, Chen Z, Zhu D, Wang S, Zhang S, Zhang J, Zhang H, Nie L, Huang M, Park JI, Hart T, Jiang D, Jiang K, Chen J. Feng X, et al. Among authors: nie l. Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2406325121. doi: 10.1073/pnas.2406325121. Epub 2024 Sep 19. Proc Natl Acad Sci U S A. 2024. PMID: 39298484 Free PMC article.
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial.
Zhong J, Fei K, Wu L, Li B, Wang Z, Cheng Y, Li X, Wang X, Han L, Wu X, Fan Y, Yu Y, Lv D, Shi J, Huang J, Zhou S, Han B, Sun G, Guo Q, Ji Y, Zhu X, Hu S, Zhang W, Wang Q, Jia Y, Wang Z, Song Y, Wu J, Shi M, Li X, Han Z, Liu Y, Yu Z, Liu AW, Wang X, Zhou C, Zhong D, Miao L, Zhang Z, Zhao H, Yang J, Wang D, Wang Y, Li Q, Zhang X, Ji M, Yang Z, Cui J, Gao B, Wang B, Liu H, Nie L, He M, Jin S, Gu W, Shu Y, Zhou T, Feng J, Yang X, Huang C, Zhu B, Yao Y, Yao S, Yu J, Cai SL, Cai Y, Xu J, Zhuang W, Luo X, Duan J, Wang J. Zhong J, et al. Among authors: nie l. Signal Transduct Target Ther. 2024 Dec 24;9(1):369. doi: 10.1038/s41392-024-02087-6. Signal Transduct Target Ther. 2024. PMID: 39715755 Free PMC article. Clinical Trial.
Circulating tumor DNA-based stratification strategy for chemotherapy plus PD-1 inhibitor in advanced non-small-cell lung cancer.
Xu J, Wan R, Cai Y, Cai S, Wu L, Li B, Duan J, Cheng Y, Li X, Wang X, Han L, Wu X, Fan Y, Yu Y, Lv D, Shi J, Huang J, Zhou S, Han B, Sun G, Guo Q, Ji Y, Zhu X, Hu S, Zhang W, Wang Q, Jia Y, Wang Z, Song Y, Wu J, Shi M, Li X, Han Z, Liu Y, Yu Z, Liu AW, Wang X, Zhou C, Zhong D, Miao L, Zhang Z, Zhao H, Yang J, Wang D, Wang Y, Li Q, Zhang X, Ji M, Yang Z, Cui J, Gao B, Wang B, Liu H, Nie L, He M, Jin S, Gu W, Shu Y, Zhou T, Feng J, Yang X, Huang C, Zhu B, Yao Y, Yu J, Yao S, Shen R, Wang Z, Wang J. Xu J, et al. Among authors: nie l. Cancer Cell. 2024 Sep 9;42(9):1598-1613.e4. doi: 10.1016/j.ccell.2024.08.013. Cancer Cell. 2024. PMID: 39255777 Free article.
Cell cycle progression of under-replicated cells.
Huang M, Yang C, Nie L, Zhang H, Zhu D, Wang C, Park JM, Srivastava M, Mosa E, Li S, Tang M, Feng X, Keast SJ, Stossi F, Chen J. Huang M, et al. Among authors: nie l. Nucleic Acids Res. 2025 Jan 7;53(1):gkae1311. doi: 10.1093/nar/gkae1311. Nucleic Acids Res. 2025. PMID: 39778868 Free PMC article.
Lysine succinylation precisely controls normal erythropoiesis.
Hu B, Gong H, Nie L, Zhang J, Li Y, Liu D, Zhang H, Zhang H, Han L, Yang C, Li M, Xu W, Nakamura Y, Shi L, Ye M, Hillyer CD, Mohandas N, Liang L, Sheng Y, Liu J. Hu B, et al. Among authors: nie l. Haematologica. 2025 Feb 1;110(2):397-413. doi: 10.3324/haematol.2024.285752. Haematologica. 2025. PMID: 39415677 Free PMC article.
2,814 results